Maternal and postnatal dietary probiotic supplementation enhances splenic regulatory T helper cell population and reduces ovalbumin allergen-induced hypersensitivity responses in mice

Immunobiology

Volumn 219, Issue 5, 2014, Pages 367-376

  Toomer, Ondulla T ^a   Ferguson, Martine ^a   Pereira, Marion ^a   Do, Andrew ^a   Bigley, Elmer ^a   Gaines, Dennis ^a   Williams, Kristina ^a  

^a CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

Author keywords

CT; FACS; Food allergy; FoxP3; Mouse; OVA; Ovalbumin; PBS; PCR; Probiotics

Indexed keywords

CD86 ANTIGEN; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; EOTAXIN; GAMMA INTERFERON; IMMUNOGLOBULIN E; INTERLEUKIN 13; INTERLEUKIN 17; INTERLEUKIN 18; INTERLEUKIN 23P19; INTERLEUKIN 27; MESSENGER RNA; OVALBUMIN; PATTERN RECOGNITION RECEPTOR; PROBIOTIC AGENT; PROTEIN NFATC2IP; PROTEIN SFTPD; RANTES; STAT1 PROTEIN; TRANSCRIPTION FACTOR; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG;

ADAPTIVE IMMUNITY; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIAL COLONIZATION; CD4 LYMPHOCYTE COUNT; CD4+ CD25+ T LYMPHOCYTE; CELLULAR IMMUNITY; CONTROLLED STUDY; DIET SUPPLEMENTATION; DOWN REGULATION; EFFECTOR CELL; FECES ANALYSIS; FLUORESCENCE ACTIVATED CELL SORTING; FOOD ALLERGY; GENE; GENE EXPRESSION; IMMUNOGLOBULIN BLOOD LEVEL; IMMUNOPROPHYLAXIS; IMMUNOSTIMULATION; LACTOBACILLUS ACIDOPHILUS; LYMPHOCYTE SUBPOPULATION; MATERNAL CARE; MOUSE; NONHUMAN; PERINATAL PERIOD; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PUP (RODENT); REGULATORY T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; TGF BETA GENE; TH1 CELL; TH1 TH2 BALANCE; TH17 CELL; TH2 CELL; UPREGULATION; WEIGHT GAIN;

FOOD ALLERGY; MOUSE; OVALBUMIN; PROBIOTICS;

ALLERGENS; ANIMALS; ANIMALS, NEWBORN; ANTIBODY SPECIFICITY; BODY WEIGHT; DIETARY SUPPLEMENTS; DISEASE MODELS, ANIMAL; FEMALE; FOOD HYPERSENSITIVITY; GASTROINTESTINAL TRACT; IMMUNOGLOBULIN E; LACTOBACILLUS ACIDOPHILUS; MATERNAL EXPOSURE; MICE; OVALBUMIN; PROBIOTICS; SPLEEN; T-LYMPHOCYTES, HELPER-INDUCER;

EID: 84896403253     PISSN: 01712985     EISSN: 18783279     Source Type: Journal    
DOI: 10.1016/j.imbio.2014.01.003     Document Type: Article

References (50)

1. Abrahamsson T.R., Jakobsson T., Böttcher M.F., Fredrikson M., Jenmalm M.C., Björkstén B., Oldaeus G. Probiotics in prevention of IgE-associated eczema: a double-blind, randomized, placebo-controlled trial. J. Allergy Clin. Immunol. 2007, 119(5):1174-1180.
2. Adam E., Delbrassine L., Bouillot C., Reynders V., Mailleux A.C., Muraille E., Jacquet A. Probiotic Escherichia coli Nissle 1917 activates DC and prevents house dust mite allergy through a TLR4-dependent pathway. Eur. J. Immunol. 2010, 40(7):1995-2005.
3. Barletta B., Rossi G., Schiavi E., Butteroni C., Corinti S., Boirivant M., Di Felice G. Probiotic VSL#3-induced TGF-β ameliorates food allergy inflammation in a mouse model of peanut sensitization through the induction of regulatory T cells in the gut mucosa. Mol. Nutr. Food Res. 2013, (Epub ahead of print).
4. Björkstén B., Sepp E., Julge K., Voor T., Mikelsaar M. Allergy development and the intestinal microflora during the first year of life. J. Allergy Clin. Immunol. 2001, 108(4):516-520.
5. Brandtzaeg P. The mucosal immune system and its integration with the mammary glands. J. Pediatr. 2010, 156(2):S8-S15.
6. Casas R., Björkstén B. Detection of Fel d 1-immunoglobulin G immune complexes in cord blood and sera from allergic and non-allergic mothers. Pediatr. Allergy Immunol. 2001, 12(2):59-64.
7. Chen C.C., Louie S., Shi H.N., Walker W.A. Preinoculation with the probiotic Lactobacillus acidophilus early in life effectively inhibits murine Citrobacter rodentium colitis. Pediatr. Res. 2005, 58:1185-1191.
8. Donkor O.N., Ravikumar M., Proudfoot O., Day S.L., Apostolopoulos V., Paukovics G., Vasiljevic T., Nutt S.L., Gill H. Cytokine profile and induction of T helper type 17 and regulatory T cells by human peripheral mononuclear cells after microbial exposure. Clin. Exp. Immunol. 2012, 167(2):282-295.
9. Fanaro S., Chierici R., Guerrini P., Vigi V. Intestinal microflora in early infancy: composition and development. Acta Paediatr. Suppl. 2003, 91(441):48-55.
10. Fontenot J.D., Gavin M.A., Rudensky A.Y. Foxp3 programs the development and function of CD4+CD25+ regulatory T cells. Nat. Immunol. 2003, 4(4):330-336.
11. Foye O.T., Huang I.F., Chiou C.C., Walker W.A., Shi H.N. Early administration of probiotic Lactobacillus acidophilus and/or prebiotic inulin attenuates pathogen-mediated intestinal inflammation and Smad 7 cell signaling. FEMS Immunol. Med. Microbiol. 2012, 65(3):467-480.
12. Holt P.G. Environmental factors and primary T-cell sensitisation to inhalant allergens in infancy: reappraisal of the role of infections and air pollution. Pediatr. Allergy Immunol. 1995, 1:1-10.
13. Holt P.G., Clough J.B., Holt B.J., Baron-Hay M.J., Rose A.H., Robinson B.W., Thomas W.R. Genetic 'risk' for atopy is associated with delayed postnatal maturation of T-cell competence. Clin. Exp. Allergy 1992, 22(12):1093-1099.
14. Holt P.G., Sly P.D., Björkstén B. Atopic versus infectious diseases in childhood: a question of balance?. Pediatr. Allergy Immunol. 1997, 8(2):53-58.
15. Holt P.G., O'Keeffe P., Holt B.J., Upham J.W., Baron-Hay M.J., Suphioglu C., Knox B., Stewart G.A., Thomas W.R., Sly P.D. T-cell priming against environmental allergens in human neonates: sequential deletion of food antigen reactivity during infancy with concomitant expansion of responses to ubiquitous inhalant allergens. Pediatr. Allergy Immunol. 1995, 6(2):85-90.
16. Hoque S.S., Faruque A.S., Mahalanabis D., Hasnat A. Infectious agents causing acute watery diarrhoea in infants and young children in Bangladesh and their public health implications. J. Trop. Pediatr. 1994, 40(6):351-354.
17. Isolauri E., Salminen S. Probiotics: use in allergic disorders: a Nutrition, Allergy, Mucosal Immunology, and Intestinal Microbiota (NAMI) Research Group Report. J. Clin. Gastroenterol. 2008, 42(2):S91-S96.
18. Ivory K., Chambers S.J., Pin C., Prieto E., Arqués J.L., Nicoletti C. Oral delivery of Lactobacillus casei Shirota modifies allergen-induced immune responses in allergic rhinitis. Clin. Exp. Allergy 2008, 38(8):1282-1289.
19. Kalliomäki M., Salminen S., Arvilommi H., Kero P., Koskinen P., Isolauri E. Probiotics in primary prevention of atopic disease: a randomised placebo-controlled trial. Lancet 2001, 357(9262):1076-1079.
20. Kaplan J.L., Shi H.N., Walker W.A. The role of microbes in developmental immunologic programming. Pediatr. Res. 2011, 69(6):465-472.
21. Kidd P. Th1/Th2 balance: the hypothesis, its limitations, and implications for health and disease. Altern. Med. Rev. 2003, 8(3):223-246.
22. Kim H., Kwack K., Kim D.Y., Ji G.E. Oral probiotic bacterial administration suppressed allergic responses in an ovalbumin-induced allergy mouse model. FEMS Immunol. Med. Microbiol. 2005, 45(2):259-267.
23. Kim J.Y., Choi Y.O., Ji G.E. Effect of oral probiotics (Bifidobacterium lactis AD011 and Lactobacillus acidophilus AD031) administration on ovalbumin-induced food allergy mouse model. J. Microbiol. Biotechnol. 2008, 18(8):1393-1400.
24. Kim J.Y., Kwon J.H., Ahn S.H., Lee S.I., Han Y.S., Choi Y.O., Lee S.Y., Ahn K.M., Ji G.E. Effect of probiotic mix (Bifidobacterium bifidum, Bifidobacterium lactis, Lactobacillus acidophilus) in the primary prevention of eczema: a double-blind, randomized, placebo-controlled trial. Pediatr. Allergy Immunol. 2010, 21:386-393.
25. Kobayashi T., Suzuki T., Kaji R., Serata M., Nagata T., Ando M., Iizuka R., Tsujibe S., Murakami J., Kiyoshima-Shibata J., Kato I., Nanno M., Shida K. Probiotic upregulation of peripheral IL-17 responses does not exacerbate neurological symptoms in experimental autoimmune encephalomyelitis mouse models. Immunopharmacol. Immunotoxicol. 2012, 34(3):423-433.
26. Kuitunen M., Kukkonen K., Juntunen-Backman K., Korpela R., Poussa T., Tuure T., Haahtela T., Savilahti E. Probiotics prevent IgE-associated allergy until age 5 years in cesarean-delivered children but not in the total cohort. J. Allergy Clin. Immunol. 2009, 123(2):335-341.
27. Lan Q., Fan H., Quesniaux V., Ryffel B., Liu Z., Zheng S.G. Induced Foxp3(+) regulatory T cells: a potential new weapon to treat autoimmune and inflammatory diseases?. J. Mol. Cell Biol. 2012, 4(1):22-28.
28. Lavasani S., Dzhambazov B., Nouri M., Fåk F., Buske S., Molin G., Thorlacius H., Alenfall J., Jeppsson B., Weström B. A novel probiotic mixture exerts a therapeutic effect on experimental autoimmune encephalomyelitis mediated by IL-10 producing regulatory T cells. PLoS ONE 2010, 5(2):e9009.
29. Liao S.Y., Liao T.N., Chiang B.L., Huang M.S., Chen C.C., Chou C.C., Hsieh K.H. Decreased production of IFN gamma and increased production of IL-6 by cord blood mononuclear cells of newborns with a high risk of allergy. Clin. Exp. Allergy 1996, 26(4):397-405.
30. Lin W., Truong N., Grossman W.J., Haribhai D., Williams C.B., Wang J., Martín M.G., Chatila T.A. Allergic dysregulation and hyperimmunoglobulinemia E in Foxp3 mutant mice. J. Allergy Clin. Immunol. 2005, 116(5):1106-1115.
31. Lodinová-Zádníková R., Prokesová L., Kocourková I., Hrdý J., Zizka J. Prevention of allergy in infants of allergic mothers by probiotic Escherichia coli. Int. Arch. Allergy Immunol. 2010, 153(2):201-206.
32. Martinez F.D., Stern D.A., Wright A.L., Holberg C.J., Taussig L.M., Halonen M. Association of interleukin-2 and interferon-gamma production by blood mononuclear cells in infancy with parental allergy skin tests and with subsequent development of atopy. J. Allergy Clin. Immunol. 1995, 96(5 Pt 1):652-660.
33. Meyaard L., Hovenkamp E., Otto S.A., Miedema F. IL-12-induced IL-10 production by human T cells as a negative feedback for IL-12-induced immune responses. J. Immunol. 1996, 156(8):2776-2782.
34. Miles E.A., Warner J.A., Jones A.C., Colwell B.M., Bryant T.N., Warner J.O. Peripheral blood mononuclear cell proliferative responses in the first year of life in babies born to allergic parents. Clin. Exp. Allergy 1996, 26(7):780-788.
35. Moussu H., Van Overtvelt L., Horiot S., Tourdot S., Airouche S., Zuercher A., Holvoet S., Prioult G., Nutten S., Mercenier A., Mascarell L., Moingeon P. Bifidobacterium bifidum NCC 453 promotes tolerance induction in murine models of sublingual immunotherapy. Int. Arch. Allergy Immunol. 2012, 158(1):35-42.
36. Newburg D.S. Neonatal protection by an innate immune system of human milk consisting of oligosaccharides and glycans. J. Anim. Sci. 2009, 87(13):26-34.
37. Newburg D.S., Ruiz-Palacios G.M., Morrow A.L. Human milk glycans protect infants against enteric pathogens. Annu. Rev. Nutr. 2005, 25:37-58.
38. Ogra P.L., Welliver R.C. Effects of early environment on mucosal immunologic homeostasis, subsequent immune responses and disease outcome. Nestle Nutr. Workshop Ser. Pediatr. Program 2008, 61:145-181.
39. Piccinni M.P., Beloni L., Giannarini L., Livi C., Scarselli G., Romagnani S., Maggi E. Abnormal production of T helper 2 cytokines interleukin-4 and interleukin-5 by T cells from newborns with atopic parents. Eur. J. Immunol. 1996, 26(10):2293-2298.
40. Prescott S.L., Macaubas C., Holt B.J., Smallacombe T.B., Loh R., Sly P.D., Holt P.G. Transplacental priming of the human immune system to environmental allergens: universal skewing of initial T cell responses toward the Th2 cytokine profile. J. Immunol. 1998, 160(10):4730-4737.
41. Rinas U., Horneff G., Wahn V. Interferon-gamma production by cord-blood mononuclear cells is reduced in newborns with a family history of atopic disease and is independent from cord blood IgE-levels. Pediatr. Allergy Immunol. 1993, 4(2):60-64.
42. Rovedatti L., Kudo T., Biancheri P., Sarra M., Knowles C.H., Rampton D.S., Corazza G.R., Monteleone G., Di Sabatino A., Macdonald T.T. Differential regulation of interleukin 17 and interferon gamma production in inflammatory bowel disease. Gut 2009, 58(12):1629-1636.
43. Saito S., Yoshida M., Ichijo M., Ishizaka S., Tsujii T. Transforming growth factor-beta (TGF-beta) in human milk. Clin. Exp. Immunol. 1993, 94:220-224.
44. Satwani H., Rehman A., Ashraf S., Hassan A. Is serum total IgE levels a good predictor of allergies in children?. J. Pak. Med. Assoc. 2009, 59(10):698-702.
45. Schiavi E., Barletta B., Butteroni C., Corinti S., Boirivant M., Di Felice G. Oral therapeutic administration of a probiotic mixture suppresses established Th2 responses and systemic anaphylaxis in a murine model of food allergy. Allergy 2011, 66(4):499-508.
46. Sjögren Y.M., Tomicic S., Lundberg A., Böttcher M.F., Björkstén B., Sverremark-Ekström E., Jenmalm M.C. Influence of early gut microbiota on the maturation of childhood mucosal and systemic immune responses. Clin. Exp. Allergy 2009, 39(12):1842-1851.
47. Su W., Fan H., Chen M., Wang J., Brand D., He X., Quesniaux V., Ryffel B., Zhu L., Liang D., Zheng S.G. Induced CD4+ forkhead box protein-positive T cells inhibit mast cell function and established contact hypersensitivity through TGF-β1. J. Allergy Clin. Immunol. 2012, 130(2):444-452.
48. Tannock G.W., Fuller R., Smith S.L., Hall M.A. Plasmid profiling of members of the family Enterobacteriaceae, lactobacilli, and bifidobacteria to study the transmission of bacteria from mother to infant. J. Clin. Microbiol. 1990, 28(6):1225-1228.
49. Thang C.L., Boye J.I., Zhao X. Low doses of allergen and probiotic supplementation separately or in combination alleviate allergic reactions to cow β-lactoglobulin in mice. J. Nutr. 2013, 143(2):136-141.
50. Wickens K., Black P.N., Stanley T.V., Mitchell E., Fitzharris P., Tannock G.W., Purdie G., Crane J. A differential effect of 2 probiotics in the prevention of eczema and atopy: a double-blind, randomized, placebo-controlled trial. J. Allergy Clin. Immunol. 2008, 122(4):788-794.